LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
SK-BR-3 | WZ-4-145 | 10.0 | uM | LJP6 | 0.2553 | 0.0336 | -0.2450 | 0.1176 |
SK-BR-3 | XMD16-144 | 10.0 | uM | LJP5 | 0.2745 | 0.0122 | -0.2108 | 0.0864 |
SK-BR-3 | Brivanib | 10.0 | uM | LJP5 | 0.9030 | 0.0320 | 0.8350 | 0.0558 |
SK-BR-3 | Buparlisib | 10.0 | uM | LJP5 | 0.2276 | 0.0042 | -0.2883 | 0.0825 |
SK-BR-3 | BX-912 | 10.0 | uM | LJP5 | 0.3797 | 0.0255 | -0.0310 | 0.0496 |
SK-BR-3 | Canertinib | 10.0 | uM | LJP6 | 0.2673 | 0.0042 | -0.2207 | 0.0671 |
SK-BR-3 | Celastrol | 10.0 | uM | LJP6 | 0.2848 | 0.0159 | -0.1893 | 0.0474 |
SK-BR-3 | CGP60474 | 10.0 | uM | LJP5 | 0.2228 | 0.0188 | -0.2992 | 0.1081 |
SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 0.1653 | 0.0190 | -0.3933 | 0.1036 |
SK-BR-3 | CHIR-99021 | 10.0 | uM | LJP6 | 0.6624 | 0.0499 | 0.4290 | 0.1084 |
SK-BR-3 | CP724714 | 10.0 | uM | LJP5 | 0.3507 | 0.0112 | -0.0801 | 0.0453 |
SK-BR-3 | CP466722 | 10.0 | uM | LJP5 | 0.6702 | 0.1754 | 0.4811 | 0.2785 |
SK-BR-3 | Crizotinib | 10.0 | uM | LJP5 | 0.3028 | 0.0079 | -0.1607 | 0.0566 |
SK-BR-3 | Momelotinib | 10.0 | uM | LJP5 | 0.4329 | 0.0336 | 0.0610 | 0.0188 |
SK-BR-3 | Dasatinib | 10.0 | uM | LJP5 | 0.4018 | 0.0370 | 0.0049 | 0.0710 |
SK-BR-3 | Dasatinib | 10.0 | uM | LJP6 | 0.2314 | 0.0092 | -0.2795 | 0.0621 |
SK-BR-3 | Dovitinib | 10.0 | uM | LJP5 | 0.4756 | 0.0224 | 0.1301 | 0.0188 |
SK-BR-3 | Enzastaurin | 10.0 | uM | LJP5 | 0.9905 | 0.0686 | 0.9905 | 0.1195 |
SK-BR-3 | Erlotinib | 10.0 | uM | LJP5 | 0.4894 | 0.0073 | 0.1483 | 0.0571 |
SK-BR-3 | Foretinib | 10.0 | uM | LJP5 | 0.3449 | 0.0158 | -0.0908 | 0.0613 |
SK-BR-3 | R406 | 10.0 | uM | LJP6 | 0.7507 | 0.0193 | 0.5882 | 0.0085 |
SK-BR-3 | Pictilisib | 10.0 | uM | LJP6 | 0.3569 | 0.0275 | -0.0745 | 0.0966 |
SK-BR-3 | Gefitinib | 10.0 | uM | LJP6 | 0.4241 | 0.0162 | 0.0389 | 0.0730 |
SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 0.1761 | 0.0205 | -0.3771 | 0.1129 |
SK-BR-3 | Geldanamycin | 10.0 | uM | LJP6 | 0.1901 | 0.0054 | -0.3491 | 0.0711 |